Staccato Prochlorperazine Single Dose PK Study

ClinicalTrials.gov ID: NCT00610727

Public ClinicalTrials.gov record NCT00610727. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Tolerability, Safety and Pharmacokinetics of a Single Dose of Staccato™ Prochlorperazine for Inhalation in Normal, Healthy Volunteers

Study identification

NCT ID: NCT00610727
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Nova Pneuma Inc.; Industry
Enrollment: 54 participants

Conditions and interventions

Conditions

Migraine

Interventions

Prochlorperazine 0.5 mg IV over 5 sec Drug
Inhaled prochlorperazine 0.625 mg Drug
Inhaled prochlorperazine 1.25 mg Drug
Inhaled prochlorperazine 2.5 mg Drug
Inhaled prochlorperazine 5 mg Drug
Inhaled prochlorperazine 10 mg Drug
Inhaled placebo Drug
Prochlorperazine 10 mg IV over 5 sec Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 45 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2004
Primary completion: Sep 30, 2004
Completion: Sep 30, 2004
Last update posted: Apr 21, 2026

2004

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
PPD Phase I Clinic	Austin	Texas	78704-7016	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00610727, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 21, 2026 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00610727 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →